RT Journal Article
SR Electronic
T1 Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007126
DO 10.1136/jitc-2023-007126
VO 11
IS 9
A1 Masuda, Jun
A1 Sakai, Hitomi
A1 Tsurutani, Junji
A1 Tanabe, Yuko
A1 Masuda, Norikazu
A1 Iwasa, Tsutomu
A1 Takahashi, Masato
A1 Futamura, Manabu
A1 Matsumoto, Koji
A1 Aogi, Kenjiro
A1 Iwata, Hiroji
A1 Hosonaga, Mari
A1 Mukohara, Toru
A1 Yoshimura, Kiyoshi
A1 Imamura, Chiyo K
A1 Miura, Sakiko
A1 Yamochi, Toshiko
A1 Kawabata, Hidetaka
A1 Yasojima, Hiroyuki
A1 Tomioka, Nobumoto
A1 Yoshimura, Kenichi
A1 Takano, Toshimi
YR 2023
UL http://jitc.bmj.com/content/11/9/e007126.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.